DRUG earnings per share for the last quarter are -0.13 USD whereas the estimation was -0.44 USD which accounts for 71.67% surprise. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of DRUG earnings per share and revenue dynamics.